How profitable was Columbia/HCA in 1994, and what drove the improvement?

Income from continuing operations rose 29% to $745 million ($2.13 per share), and pretax margin improved to 11.1%. The main drivers were revenue growth from acquisitions and outpatient services, lower interest expense from debt refinancing, improved staffing efficiency (salaries fell to 40.8% of revenue from 41.1%), and lower supply costs (15.2% of revenue versus 16.2%). Excluding non-recurring charges, EPS was $2.42, up about 22%.

What is the Healthtrust Merger and how could it change the company?

The merger combines Columbia/HCA with Healthtrust, which operates 116 hospitals in 22 states with about $3.4 billion in annual revenue. Healthtrust shareholders receive 0.88 Columbia/HCA shares per share. Management expects a pooling-of-interests treatment and about $125 million in annual cost savings, but the filing warns integration could be difficult. The deal is conditioned on an FTC consent agreement and is expected to close in April 1995, with an estimated $70 million second-quarter 1995 earnings hit from refinancing and merger costs.

How large is the IRS tax dispute, and is it a serious risk?

The IRS is claiming about $544 million in additional taxes and roughly $956 million in interest for 1981 through 1990 for HCA's returns, with a total cited as about $1.5 billion. Management believes HCA properly reported its income and that the outcome will not have a material adverse effect. However, the filing explicitly says that if most of the IRS positions were upheld, financial position, results and liquidity would be materially harmed. A Tax Court decision is expected in 1995, so this is a key item to watch.

How dependent is the company on government reimbursement?

Medicare accounted for 34% of 1994 patient revenue and Medicaid for 5%, with the remaining 61% from other payers, including discounted commercial and managed care contracts. Medicare admissions were 39% of the total. Management expects the Medicare PPS rate increase to be about 2% in 1995 and says its ability to raise non-Medicare prices is limited. Proposed federal outpatient PPS and state Medicaid funding reductions present further risk to reimbursement.

What is the company's debt and cash flow position?

Total debt was $3.93 billion at year-end 1994, up from $3.70 billion, and long-term debt was $3.85 billion. Net cash from continuing operations was $1.3 billion, which covered capital expenditures of $975 million. Working capital was $783 million. Management says cash flow and its revolving credit facilities are sufficient for expected needs, and the company plans to increase its credit facilities to $3.75 billion after the Healthtrust Merger.

HCA 10-K FY1994 Annual Report — Revenue, Net Income, EPS

01—Abstract

Summary

Summary of the 10-K filed March 31, 1995. Cited figures are marked; the original filing is the authoritative source.

Columbia/HCA Healthcare Corporation's 1994 10-K shows a company at a peak of scale and earnings momentum, but one that is simultaneously absorbing large acquisitions and carrying significant unresolved tax exposure.

Revenues rose 9% to $11.1 billion^a in 1994, and income from continuing operations before income taxes increased 27% to $1.23 billion, with pretax margin expanding to 11.1% from 9.4%. Excluding non-recurring charges of $159 million tied to the HCA Merger, pretax income rose 24% to $1.39 billion and margin reached 12.5%. Earnings per share from continuing operations were $2.13, or $2.42 excluding non-recurring items.

Much of the improvement came from lower interest expense after refinancing about $2.2 billion^b of high-coupon debt, and from better staffing and supply-cost discipline. Same-hospital admissions grew only 1.5%, so the top-line gains depended heavily on acquisitions, the MCA Merger, and a 43.6% jump in same-hospital outpatient visits. Balance sheet and cash flow remain solid but leveraged.

Long-term debt was $3.9 billion^c, operating cash flow was roughly $1.3 billion, and capital expenditures were $975 million. Total assets grew to $12.3 billion, largely from the purchase-accounted MCA Merger and related intangibles, which rose to $2.3 billion. The most significant risk flagged is the IRS dispute: the agency claims about $1.5 billion in additional taxes and interest for 1981 through 1990.

Management believes it will not have a material adverse effect, but the filing states plainly that an adverse outcome would materially harm financial position, results and liquidity. Other overhangs include Medicare and Medicaid reimbursement pressure, a federal proposal to extend prospective payment to outpatient services, a pending Healthtrust merger expected to close in April 1995, and several shareholder and ERISA lawsuits. The pending Healthtrust Merger, approved by both shareholder groups on February 28, 1995, is the dominant near-term event.

It is expected to be accounted for as a pooling of interests and projected to yield about $125 million^d in annual cost savings, though the filing warns integration risk is real. Management expects roughly $70 million of refinancing losses and merger-related charges to hit second-quarter 1995 earnings. For investors, the 1994 results show a strong operating and earnings trajectory, while the Healthtrust integration, the IRS outcome, and the government reimbursement environment are the key variables to monitor.

02—Key points

Key Highlights

Revenues rose 9% to $11.1 billion in 1994, driven mainly by acquisitions, outpatient growth, price increases and same-hospital inpatient volume gains of 1.5%.
Pretax income from continuing operations grew 27% to $1.23 billion, with pretax margin up to 11.1% from 9.4%; excluding $159 million of non-recurring HCA Merger charges, pretax income rose 24% to $1.39 billion (12.5% margin).
EPS from continuing operations was $2.13 (up 25% from $1.70); excluding non-recurring items it was $2.42, up about 22%.
Interest expense fell to $248 million from $321 million after refinancing about $2.2 billion of high-coupon debt, at an after-tax refinancing loss of $115 million.
The pending Healthtrust Merger (0.88 Columbia/HCA shares per Healthtrust share) was approved by shareholders on February 28, 1995 and is expected to close in April 1995, with projected annual savings of about $125 million.
The IRS claims roughly $1.5 billion in additional taxes and interest for prior years; management says the outcome should not be material, but an adverse result would materially impair financial position and liquidity.
Medicare represented 34% of 1994 patient revenues and reimbursement pressures persist, with the federal outpatient PPS proposal and a limited 2% Medicare payment increase expected for 1995.

03—Questions

Frequently Asked Questions

How profitable was Columbia/HCA in 1994, and what drove the improvement?
Income from continuing operations rose 29% to $745 million ($2.13 per share), and pretax margin improved to 11.1%. The main drivers were revenue growth from acquisitions and outpatient services, lower interest expense from debt refinancing, improved staffing efficiency (salaries fell to 40.8% of revenue from 41.1%), and lower supply costs (15.2% of revenue versus 16.2%). Excluding non-recurring charges, EPS was $2.42, up about 22%.
What is the Healthtrust Merger and how could it change the company?
The merger combines Columbia/HCA with Healthtrust, which operates 116 hospitals in 22 states with about $3.4 billion in annual revenue. Healthtrust shareholders receive 0.88 Columbia/HCA shares per share. Management expects a pooling-of-interests treatment and about $125 million in annual cost savings, but the filing warns integration could be difficult. The deal is conditioned on an FTC consent agreement and is expected to close in April 1995, with an estimated $70 million second-quarter 1995 earnings hit from refinancing and merger costs.
How large is the IRS tax dispute, and is it a serious risk?
The IRS is claiming about $544 million in additional taxes and roughly $956 million in interest for 1981 through 1990 for HCA's returns, with a total cited as about $1.5 billion. Management believes HCA properly reported its income and that the outcome will not have a material adverse effect. However, the filing explicitly says that if most of the IRS positions were upheld, financial position, results and liquidity would be materially harmed. A Tax Court decision is expected in 1995, so this is a key item to watch.
How dependent is the company on government reimbursement?
Medicare accounted for 34% of 1994 patient revenue and Medicaid for 5%, with the remaining 61% from other payers, including discounted commercial and managed care contracts. Medicare admissions were 39% of the total. Management expects the Medicare PPS rate increase to be about 2% in 1995 and says its ability to raise non-Medicare prices is limited. Proposed federal outpatient PPS and state Medicaid funding reductions present further risk to reimbursement.
What is the company's debt and cash flow position?
Total debt was $3.93 billion at year-end 1994, up from $3.70 billion, and long-term debt was $3.85 billion. Net cash from continuing operations was $1.3 billion, which covered capital expenditures of $975 million. Working capital was $783 million. Management says cash flow and its revolving credit facilities are sufficient for expected needs, and the company plans to increase its credit facilities to $3.75 billion after the Healthtrust Merger.

04—Continue

← View all 10-K filings